BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 25, 2021
View Archived Issues
Platelets release antigenic DNA in lupus
Read More
Intracranial samples give glimpse into stroke response
Read More
New phase II trial evaluates BIVV-020 in chronic inflammatory demyelinating polyneuropathy
Read More
Janssen opens phase III study of rilematovir in neonates, infants and children with RSV infection
Read More
Enrollment opens in phase II study of maralixibat for infants with biliary atresia
Read More
Phase III trial of Otividex for Meniere's disease does not meet primary endpoint
Read More
Aridis announces new inhaled antibody for COVID-19
Read More
Enrollment completed in phase II study of SSS-06 long-acting erythropoietin-stimulating protein
Read More
Pelareorep plus CAR T-cell therapy show synergistic activity in preclinical models of solid tumors
Read More
Carragelose lozenges show promising activity against respiratory viruses including SARS-CoV-2
Read More
Heparegenix patents MAP2K4 inhibitors
Read More
Shenzhen Chipscreen Biosciences identifies new THR beta agonists
Read More
Integral BioSciences divulges Chk1 inhibitors
Read More
Medshine Discovery synthesizes PARP-1 inhibitors
Read More
New PTPN11 inhibitors presented by Etern Biopharma
Read More
Salarius initiates expansion stage for phase I/II study of seclidemstat in Ewing sarcoma
Read More
Longeveron completes phase I study of Lomecel-B in hypoplastic left heart syndrome
Read More
Benitec reports interim data on pilot dosing study of BB-301 for OPMD
Read More
Constant Therapeutics initiates phase II study of TXA-27 in patients with COVID-19 in Israel
Read More
Novel model of age-related hearing loss with consistent flat cochlear epithelium phenotype
Read More
New model developed for testing drugs for Nav1.9-related neuropathic pain
Read More
Decibel Therapeutics presents DB-OTO for genetic hearing loss
Read More
Generex reports data on Ii-Key-SARS-CoV-2 vaccine in transgenic mouse model
Read More
Bacterial protease takes on "undruggable" oncoprotein
Read More
Insilico Medicine announces preclinical candidate for IPF
Read More
Locus Biosciences completes phase Ib study of LBP-EC01 bacteriophage therapy
Read More
Phase IIb interim data on mirdametinib in NF1-associated plexiform neurofibromas
Read More
Pfizer and BioNTech begin evaluation of third dose of COVID-19 vaccine
Read More
FDA approves Humira for pediatric patients with ulcerative colitis
Read More